North America Near Infrared Imaging Market Size, Share & Industry Trends Analysis Report By Application, By Product (Reagents and Devices), By Reagents Type (Indocyanine Green (ICG)), By Devices Type, By End-user, By Country and Growth Forecast, 2022 - 20

North America Near Infrared Imaging Market Size, Share & Industry Trends Analysis Report By Application, By Product (Reagents and Devices), By Reagents Type (Indocyanine Green (ICG)), By Devices Type, By End-user, By Country and Growth Forecast, 2022 - 2028

The North America Near Infrared Imaging Market would witness market growth of 3.4% CAGR during the forecast period (2022-2028).

By non-invasively measuring hemoglobin concentration and oxygenation in the brain, muscles, and other tissues, near infrared spectroscopy and imaging, or NIRS, can identify alterations brought on by abnormal brain activity, injury, or disease. Additionally, by offering the measurements of both deoxygenated and oxygenated hemoglobin concentrations and permitting studies in subject populations with experimental paradigms that are not susceptible to fMRI, it supports functional magnetic resonance imaging (fMRI) in the study of the brain.

In the near infrared and visible spectrums, water and deoxygenated and oxygenated hemoglobin act as the body's main absorbers. Hemoglobin strongly absorbs visible light wavelengths, and its absorption decreases dramatically above 650 nm in the near infrared.

Water absorption dramatically rises above 950 nm. So, despite the significant light scattering by tissue, there is a range between 650 and 950 nm wherein absorption of light is low, allowing the light to diffuse many centimeters and through tissue before being detected.

Due to an increase in surgical procedures, improvements in near-infrared imaging systems, and the presence of significant market participants, the United States had the largest market for this technology. Moreover, the use of near-infrared imaging is expanding in North America due to the development of aesthetic procedures and the rise in the number of lifestyle disorders requiring surgical intervention. Due to a rise in players, the number of patent applications is rising nationwide. As per the American Society of Plastic Surgeons (ASPS), millions of Americans opt for cosmetic and reconstructive surgeries of some sort.

The US market dominated the North America Near Infrared Imaging Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $651 million by 2028.The Canada market is poised to grow at a CAGR of 5.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 4.9% during (2022 - 2028).

Based on Application, the market is segmented into Preclinical Imaging, Cancer Surgeries, Gastrointestinal Surgeries, Cardiovascular Surgeries, Plastic/Reconstructive Surgeries and Others. Based on Product, the market is segmented into Reagents and Devices. Based on Reagents Type, the market is segmented into Indocyanine Green (ICG) and Others. Based on Devices Type, the market is segmented into Near-infrared Fluorescence Imaging Systems and Near-infrared Fluorescence & Bioluminescence Imaging Systems. Based on End-user, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Research Laboratories. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Olympus Corporation, Hamamatsu Photonics K.K., Carl Zeiss Meditec AG (Carl Zeiss AG), PerkinElmer, Inc., Leica Microsystems GmbH (Danaher Corporation), Shimadzu Corporation, Karl Storz SE & Co. KG, and Fluoptics SAS.

Scope of the Study

Market Segments covered in the Report:

By Application

• Preclinical Imaging
• Cancer Surgeries
• Gastrointestinal Surgeries
• Cardiovascular Surgeries
• Plastic/Reconstructive Surgeries
• Others

• Reagents
• Indocyanine Green (ICG)
• Others
• Devices
• Near-infrared Fluorescence Imaging Systems
• Near-infrared Fluorescence & Bioluminescence Imaging Systems

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Research Laboratories

• US
• Canada
• Mexico
• Rest of North America

• Medtronic PLC
• Stryker Corporation
• Olympus Corporation
• Hamamatsu Photonics K.K.
• Carl Zeiss Meditec AG (Carl Zeiss AG)
• PerkinElmer, Inc.
• Leica Microsystems GmbH (Danaher Corporation)
• Shimadzu Corporation
• Karl Storz SE & Co. KG
• Fluoptics SAS

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free